65,437 trials
Urticaria
Primary: Change From Baseline in the Urticaria Activity Score Over 7 Days (UAS7) at Day 57 — -19.16; -24.05; -11.25; -15.69 Score on a Scale — p=0.0559
Trochanteric Fracture of Femur
Primary: Number of Patient With and Without Excessive Lag Screw Sliding Distance — 109; 97; 9; 22 Participants
Wounds and Injuries
Primary: Change in Exudate Status From Baseline to Last Visit — 27; 3; 7; 40 Participants — p=0.0019
Soft Tissue Sarcoma · Bone Sarcoma
Primary: Objective Response Rate — 7; 2; 7 Participants
HER2 Positive Breast Cancer
Primary: Progression-free Survival (PFS) Per RECIST 1.1 as Determined by Blinded Independent Central Review (BICR) — 7.8; 5.6 months
Type 2 Diabetes Mellitus
Primary: Glycemic Variability: Mean Amplitude of Glucose Excursion (MAGE) — 75.2; 68.5 mg/dl — p=0.630
Pelvic Organ Prolapse
Primary: Surgical Failure — 17; 22; 20; 14 Participants
Rhinitis · Asthma · Allergy
Primary: Change in Symptoms Score After Nasal Allergen Challenge — -5; -4; -1 score on a scale
Mitral Regurgitation · Mitral Insufficiency
Primary: Safety: the Occurrence, Nature and Frequency of Significant Medical Events — 0 Events
Schizophrenia
Primary: Change From Baseline in Positive and Negative Syndrome Scale (PANSS) Total Score at Week 5 — -17.40; -5.85 score on a scale — p=<0.0001
Nonalcoholic Steatohepatitis
Primary: Mean Change in Liver Fibrosis of Corrected T1 (cT1) Mapping (LiverMultiScan -LMS) — 19.15; 1.25 milliseconds (ms) — p=0.1621
Human Immunodeficiency Virus · AIDS Virus
Primary: Change From Baseline in Plasma HIV-1 RNA — -1.39; -1.66; -0.95 log10 copies/mL
Surgery
Primary: Log Change in Bacterial Flora on Abdomen and Groin — 2.9; 3.7; 2.3; 3.0 Log (CFU)
Eosinophilic Gastroenteritis
Primary: Percent of Participants in Complete Histologic Remission — 100 percentage of participants
Hypertensive Disorder of Pregnancy
Primary: Blood Pressure (BP) Surveillance Adherence — 0.0; 61.1 percentage of recommended BPs reported